OverviewSuggest Edit

We keep life real and safe by providing botanical-DNA based security and authentication solutions and services that protect assets, products, brands, supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion.
TypePublic
HQStony Brook, US
Websiteadnas.com

Latest Updates

Employees (est.) (Sept 2019)51(-13%)
Revenue (FY, 2019)$5.4 M(+39%)
Share Price (Sept 2020)$7.8 (-5%)
Cybersecurity ratingAMore

Key People/Management at Applied DNA Sciences

James A. Hayward

James A. Hayward

Chairman of the Board, President and Chief Executive Officer
John Bitzer

John Bitzer

Director
Judy Murrah

Judy Murrah

Chief Information Officer
Beth Jantzen

Beth Jantzen

Chief Financial Officer
Show more

Applied DNA Sciences Office Locations

Applied DNA Sciences has an office in Stony Brook
Stony Brook, US (HQ)
50 Health Sciences Drive
Show all (1)

Applied DNA Sciences Financials and Metrics

Applied DNA Sciences Revenue

Applied DNA Sciences's revenue was reported to be $5.39 m in FY, 2019
USD

Revenue (Q3, 2020)

431.5k

Gross profit (Q3, 2020)

276.7k

Gross profit margin (Q3, 2020), %

64.1%

Net income (Q3, 2020)

(3.3m)

EBIT (Q3, 2020)

(3.2m)

Market capitalization (18-Sept-2020)

39.9m

Closing stock price (18-Sept-2020)

7.8

Cash (30-Jun-2020)

10.9m

EV

32.0m
Applied DNA Sciences's current market capitalization is $39.9 m.
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Revenue

968.8k1.9m2.0m2.7m9.0m4.2m4.8m3.9m5.4m

Revenue growth, %

34%231%(54%)

Cost of goods sold

746.6k1.1m1.2m877.6k

Gross profit

3.4m3.7m2.7m4.5m
Quarterly
USDQ3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Revenue

229.7k516.9k518.4k528.6k317.7k344.6k644.8k597.4k637.1k841.2k1.2m1.5m2.3m1.3m573.3k652.9k903.0k905.4k1.8m647.7k1.0m1.0m884.3k778.5k2.1m633.5k552.5k431.5k

Cost of goods sold

121.3k274.8k297.4k232.3k331.4k372.2k252.6k153.5k133.1k270.9k232.0k179.6k154.8k

Gross profit

531.6k628.2k608.0k1.6m316.2k671.8k763.8k730.8k645.3k1.8m401.5k372.9k276.7k

Gross profit Margin, %

81%70%67%87%49%64%75%83%83%87%63%67%64%
USDQ3, 2011

Financial Leverage

-0.2 x
Show all financial metrics

Applied DNA Sciences Cybersecurity Score

Cybersecurity ratingPremium dataset

A

93/100

SecurityScorecard logo

Applied DNA Sciences Online and Social Media Presence

Embed Graph

Applied DNA Sciences News and Updates

Thinking about buying stock in Achieve Life Sciences, Applied DNA Sciences, Delta Air Lines, Carnival Corp, or MGM Resorts?

NEW YORK, July 31, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ACHV, APDN, DAL, CCL, and MGM. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link....

Thinking about buying stock in Applied DNA Sciences, Microvision, Virgin Galactic, Blink Charging, or Novavax?

NEW YORK, July 17, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for APDN, MVIS, SPCE, BLNK, and NVAX. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link....

Thinking about buying stock in Citius Pharmaceuticals, Aytu Bioscience, Applied DNA Sciences, Royal Caribbean Cruises, or American Airlines?

NEW YORK, June 26, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CTXR, AYTU, APDN, RCL, and AAL. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link....

Applied DNA Reports 2020 Fiscal Second Quarter Financial Results

Applied DNA Sciences Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”) a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing that enables in vitro diagnostics, pre-clinical nucleic acid-based therapeutic drug candidates, supply chain security, anti-counterfeiting and anti-theft tech…

Applied DNA Receives Approximately $5.3 Million in Net Proceeds from Warrant Exercise

Applied DNA Sciences Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”) a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing that enables diagnostics, pre-clinical nucleic acid-based therapeutic drug candidates, supply chain security, anti-counterfeiting and anti-theft technology, h…

Applied DNA Receives Kosher Certification from Orthodox Union for Qualifying Products

Applied DNA Sciences, Inc. (“Applied DNA”, the “Company”, NASDAQ: APDN), announced receipt of certification from the Orthodox Union (OU^®) for products within the SigNature and CertainT line following a thorough evaluation of the Company’s products and manufacturing processes.
Show more

Applied DNA Sciences Blogs

Applied DNA Positions LinearDNA™ Platform as the Next Generation Manufacturing Platform for Adeno-Associated Virus-based Gene Therapies Through New Patent Filing

STONY BROOK, N.Y. – August 17, 2020 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing that enables in vitro diagnostics, pre-clinical nucleic acid-based therapeutic drug candidates, supply chain security,…

Applied DNA Receives Notice of Allowance on Second Patent Protecting Proprietary DNA Transfer System for Large-Scale Cotton Tagging

Newly allowed Patent Protects Methods of Tagging Cotton Fibers During Ginning Process STONY BROOK, N.Y. – August 12, 2020 – Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”) a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing for product authenticity and trac…

Applied DNA Reports Fiscal Third Quarter 2020 Financial Results

Company to Hold Conference Call and Webcast Today, Thursday, August 6, 2020, at 4:30 PM EDT STONY BROOK, N.Y. – August 6, 2020 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing that enables in vitro diagn…

Applied DNA’s COVID-19 Diagnostic Kit Granted FDA EUA Amendment for Use on Widely Installed RT-PCR Device and High-Throughput RNA Extraction Robotics

Applied DNA’s COVID-19 Diagnostic Kit Granted FDA EUA Amendment for Use on Widely Installed RT-PCR Device and High-Throughput RNA Extraction Robotics "We appreciate the continued collaboration of FDA in assisting us to improve the availability and throughput of our COVID-19 diagnostic kit." By Hos…

FDA Approves EUA Amendment Increasing Applied DNA’s COVID-19 Diagnostic Kit Testing Capacity Through Use Of Automated RNA Extraction And Expands Supported Platforms

STONY BROOK, N.Y. – July 31, 2020 – Applied DNA Sciences Inc. (NASDAQ: APDN) (“Applied DNA” or the  “Company”) a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing that enables in vitro diagnostics, and pre-clinical nucleic acid-based therapeutic drug candidates, today announced that …

FDA Approves EUA Amendment Increasing COVID-19 Diagnostic Kit Testing Capacity

STONY BROOK, N.Y. – July 31, 2020 – Applied DNA Sciences Inc. (NASDAQ: APDN) (“Applied DNA” or the  “Company”) a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing that enables in vitro diagnostics, and pre-clinical nucleic acid-based therapeutic drug candidates, today announced that …
Show more

Applied DNA Sciences Frequently Asked Questions

  • Who are Applied DNA Sciences key executives?

    Applied DNA Sciences's key executives are James A. Hayward, John Bitzer and Judy Murrah.

  • How many employees does Applied DNA Sciences have?

    Applied DNA Sciences has 51 employees.

  • What is Applied DNA Sciences revenue?

    Latest Applied DNA Sciences annual revenue is $5.4 m.

  • What is Applied DNA Sciences revenue per employee?

    Latest Applied DNA Sciences revenue per employee is $105.7 k.

  • Who are Applied DNA Sciences competitors?

    Competitors of Applied DNA Sciences include Wrap Technologies, Alvarado Manufacturing Company and Latch.

  • Where is Applied DNA Sciences headquarters?

    Applied DNA Sciences headquarters is located at 50 Health Sciences Drive, Stony Brook.

  • Where are Applied DNA Sciences offices?

    Applied DNA Sciences has an office in Stony Brook.

  • How many offices does Applied DNA Sciences have?

    Applied DNA Sciences has 1 office.